Regen BioPharma (RGBP) Stock Chart & Stock Price History $0.02 -0.01 (-20.38%) As of 03:52 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Regen BioPharma Stock Price Performance The Regen BioPharma (RGBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 93.07%, with a year-to-date return of -70.55%. In the past month, the stock has decreased 74.13%, reflecting recent market activity. As of the latest close, Regen BioPharma traded at $0.03 with a market cap of and volume of 209,717 shares. Receive RGBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regen BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-23.62%1 Month Performance-74.13%3 Month Performance-59.49%Year-To-Date Performance-70.55%1 Year Performance-93.07% RGBP Stock Chart for Monday, August, 25, 2025 RGBP Chart by TradingView Regen BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025$0.03$0.02-20.38%$0.03$0.02723,570 shs$0.0008/22/2025$0.03$0.03$0.03$0.02209,717 shs$0.0008/21/2025$0.03$0.03-4.06%$0.03$0.03329,707 shs$0.0008/20/2025$0.03$0.03-16.62%$0.04$0.03681,784 shs$0.0008/19/2025$0.03$0.03-6.07%$0.04$0.03123,569 shs$0.0008/18/2025$0.04$0.03-9.90%$0.04$0.03120,399 shs$0.0008/15/2025$0.04$0.04-0.26%$0.05$0.04506,775 shs$0.0008/14/2025$0.06$0.04-33.16%$0.04$0.03545,289 shs$0.0008/13/2025$0.04$0.06+44.36%$0.06$0.04142,875 shs$0.0008/12/2025$0.04$0.04$0.05$0.04274,567 shs$0.00 Get the Latest News and Ratings for RGBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regen BioPharma and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025$0.04$0.04-0.25%$0.05$0.04241,390 shs$0.0008/08/2025$0.05$0.04-16.14%$0.05$0.04288,837 shs$0.0008/07/2025$0.04$0.05+17.78%$0.05$0.04201,208 shs$0.0008/06/2025$0.04$0.04-5.81%$0.05$0.04358,969 shs$0.0008/05/2025$0.05$0.04-10.42%$0.05$0.04380,838 shs$0.0008/04/2025$0.05$0.05-12.41%$0.05$0.05256,827 shs$0.0008/01/2025$0.05$0.05+9.38%$0.07$0.05223,787 shs$0.0007/31/2025$0.05$0.05-4.02%$0.06$0.05281,856 shs$0.0007/30/2025$0.07$0.05-24.89%$0.06$0.05185,395 shs$0.0007/29/2025$0.08$0.07-14.20%$0.07$0.06341,836 shs$0.0007/28/2025$0.08$0.08+1.25%$0.09$0.07167,565 shs$0.0007/25/2025$0.09$0.08-6.98%$0.10$0.07121,781 shs$0.0007/24/2025$0.09$0.09-2.38%$0.10$0.07104,538 shs$0.00 Related Companies 180 Life Sciences Stock Chart 4D pharma Stock Chart 4Front Ventures Stock Chart Abattis Bioceuticals Stock Chart Abcam Stock Chart Acusphere Stock Chart Aeolus Pharmaceuticals Stock Chart Aesther Healthcare Acquisition Stock Chart Agentix Stock Chart Ainos Stock Chart Receive RGBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regen BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:RGBP) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regen BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regen BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access